Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| It was a great quarter and year of execution for Veeva with strength across the business and results above our guidance |
| One, we have really high market share and happy customers on our core CRM or Veeva CRM and some of the add-ons |
| What's happened is we just continue to track record of customer success, just sort of grind it out all the customers are successful with Crossix, our data network for what we're doing there is the largest and most applicable |
| How are you feeling about that? So I would say our customer success is leading the way |
| And these are small now, but they're growing rapidly on a percentage basis, and they have high potential if we can execute well |
| But we feel good about our ability to hit those operating income and our margin targets |
| So we feel good about how we've executed there |
| So that migration capability actually translates into an advantage in our enterprise sales because we have that capability and nobody else really has that capability |
| But overall, we feel really good about how we're executing in the efficiency that we have |
| So I'm really happy about it |
| Nice to see the strong guidance on fiscal '25 |
| But just know that we're executing well, and we feel good about those numbers |
| So that's a good thing that the health care system can recover |
| And I'm proud of all the team accomplished |
| And if we call that other commercial, this is some stable things like commercial content and Crossix where we are the market leaders, but we continue to grow at a moderate and steady pace and customer success is really high with those products |
| What I would say is our visibility is at least equally as good, if not better than it was in previous times |
| So real pleased that how we exited fiscal year '24, exceeding our billings guide, so executing well there |
| And I'm really happy we have some happy early customers |
| And because we have a lot of new products, we have a clear competitive advantage there, and these are mission-critical systems |
| We're sourcing data from a lot of different sources, and we have really excellent industry-leading patient tokenization process that's kind of fundamentally different than the common one out there |
| But overall, we feel really good and have conviction on the numbers we provided |
| As I think about the outlook, you have solid teens growth on subscription and billing |
| So as you can tell, I'm excited about the future, and we'll be able to show some of these products at our Customer Summit in May, especially the call center one, the service center is really coming along |
| I would, I guess, I would say we're in a pretty good position because AI really -- the durable thing about AI is the data sources, the data sources |
| It's not a positive to the revenue in the short term, but it's the right thing and it will be a positive to the revenue in the long term |
| I am excited about it |
| So now you fast forward 12 months, and from that, we've been executing well, right? We've been executing over the past year |
| We had a big clinical operations win for multiple clinical operations products |
| It's about 50% of our revenue right now, and it's about 65% of our overall opportunity, and it's growing roughly 20% or so and that will really grow well into the foreseeable future |
| And certainly, by 2030, they'll be all migrated, so it's the correct way to think about it, this re-platforming, you think about it, since we're in the life sciences industry, you could think about it as a strong medicine that Veeva has to take for the industry, right, to do this to the re-platforming |
| Statement |
|---|
| And a small number of new companies were able to get escape velocity because of the funding environment, it's tough, and it continues to be tough |
| But one of the factors you called out in your lower outlook for service its project timing |
| The emerging biotechs, the small center of the segment is still a tough sliding there |
| So I'm not -- even if we were at scale in our business, I would -- it's certainly unfortunate what happened with change, and I think it's terrible what's going on with the cyber tax, but it wouldn't affect our Compass or Crossix business |
| Now that is interesting for whoever is coding that study, but it's a bit of a headache for the people managing the study because when you have coding it's hard to keep that under control and the complexity grows and there can be errors and unforeseen things |
| I think there's a little more optimism |
| But if I could just press, why not, if your clients are getting a little more optimistic, could projects that might be stalled start to move forward discretionary spend start to come back |
| So there's a little more optimism |
| You don't do it unless you have pain in that area and not all customers have pain all at the same time |
| Then in the top 50, I would say the feeling is just kind of a bit resigned that, hey, we're in for this -- there's some global conflicts, there's inflation, there's IRA Act, but that hasn't hurt us too bad yet, so we could just keep going |
| It sounds like both of you, Peter and Brent are dissuading us from thinking that, that increased optimism would have any real impact on revenues and billings this year? I think we're hearing that message |
| So have time lines been getting more elongated? Or is it more that your expectations from some of these projects coming back is now pushed out a little bit? Brent Bowman I mean it's -- so what we said was it hasn't gotten worse or better in the last 90 days |
| We do live in some uncertain times |
| But one thing we've seem to have picked up from other vendors in the data space is that there's sort of this constant need for it, whether it be maintenance or additions to grow their data sets over time to remain competitive and maybe those are vendor-specific issues |
| So it's really a timing issue |
| I couldn't help but notice you mentioned being a little more prudent with the outlook which I think is a language you guys haven't used in the past |
| And if we see something that's not good, such as, hey, we don't have stability over multiple years or the cost is too high than we want to pay, then we just won't purchase that |
| Now we have to remain seen if we can execute well |
| And therefore, you'll lose it in the integration or the business strategy isn't actually clear because you can't say it to people |
| It's not really growing because of two things |
Please consider a small donation if you think this website provides you with relevant information